Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States-Reference-Cited by-同舟云学术

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

Published:2020-10-21 Issue:4 Volume:127 Page:609-618
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hong Sanghee¹,Brazauskas Ruta²³,Hebert Kyle M.²,Ganguly Siddhartha⁴,Abdel‐Azim Hisham⁵,Diaz Miguel Angel⁶,Beattie Sara⁷⁸,Ciurea Stefan O.⁹^ORCID,Szwajcer David¹⁰,Badawy Sherif M.¹¹¹²,Gratwohl Alois A.¹³,LeMaistre Charles¹⁴,Aljurf Mahmoud D. S. M.¹⁵,Olsson Richard F.¹⁶¹⁷,Bhatt Neel S.¹⁸,Farhadfar Nosha¹⁹^ORCID,Yared Jean A.²⁰,Yoshimi Ayami²¹,Seo Sachiko²²,Gergis Usama²³,Beitinjaneh Amer M.²⁴,Sharma Akshay²⁵,Lazarus Hillard²⁶,Law Jason²⁷,Ulrickson Matthew²⁸,Hashem Hasan²⁹,Schoemans Hélène³⁰,Cerny Jan³¹,Rizzieri David³²,Savani Bipin N.³³^ORCID,Kamble Rammurti T.³⁴,Shaw Bronwen E.²^ORCID,Khera Nandita³⁵^ORCID,Wood William A.³⁶,Hashmi Shahrukh³⁷^ORCID,Hahn Theresa³⁸,Lee Stephanie J.²¹⁸,Rizzo J. Douglas²,Majhail Navneet S.¹^ORCID,Saber Wael²

Affiliation:

1. Blood and Marrow Transplant Program Taussig Cancer CenterCleveland Clinic Cleveland Ohio

2. Center for International Blood and Marrow Transplant Research Department of Medicine Medical College of Wisconsin Milwaukee Wisconsin

3. Division of Biostatistics Institute of Health and EquityMedical College of Wisconsin Milwaukee Wisconsin

4. Division of Hematological Malignancy and Cellular Therapeutics University of Kansas Health System Kansas City Kansas

5. Division of Hematology, Oncology, and Blood & Marrow Transplantation Children's Hospital Los AngelesUniversity of Southern California Keck School of Medicine Los Angeles California

6. Department of Hematology/Oncology Hospital Infantil Universitario Nino Jesus Madrid Spain

7. Department of Psychosocial Oncology and Rehabilitation Tom Baker Cancer Centre Calgary Alberta Canada

8. Department of Oncology University of Calgary Calgary Alberta Canada

9. The University of Texas MD Anderson Cancer Center Houston Texas

10. University of Manitoba Winnipeg Manitoba Canada

11. Division of Hematology, Oncology, and Stem Cell Transplant Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois

12. Department of Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois

13. University Hospital Basel Basel Switzerland

14. Hematology and Bone Marrow Transplant, Sarah Cannon Nashville Tennessee

15. Department of Oncology King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia

16. Department of Laboratory Medicine Karolinska Institute Stockholm Sweden

17. Centre for Clinical Research Sormland Uppsala University Uppsala Sweden

18. Fred Hutchinson Cancer Research Center Seattle Washington

19. Division of Hematology/Oncology University of Florida College of Medicine Gainesville Florida

20. Blood and Marrow Transplantation Program Division of Hematology/Oncology Department of Medicine Greenebaum Comprehensive Cancer Center University of Maryland Baltimore Maryland

21. Division of Pediatric Hematology and Oncology Department of Pediatrics and Adolescent Medicine Medical Center University of Freiburg Freiburg Germany

22. Department of Hematology and Oncology Dokkyo Medical University Tochigi Japan

23. Thomas Jefferson University Philadelphia Pennsylvania

24. University of Miami Miami Florida

25. Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital Memphis Tennessee

26. University Hospitals Cleveland Medical CenterCase Western Reserve University Cleveland Ohio

27. Division of Pediatric Hematology/Oncology Floating Hospital for Children at Tufts Medical Center Boston Massachusetts

28. Banner MD Anderson Cancer Center Gilbert Arizona

29. Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation King Hussein Cancer Center Amman Jordan

30. Department of Hematology University Hospitals Leuven and Katholieke Universiteit Leuven Leuven Belgium

31. Division of Hematology/Oncology Department of Medicine University of Massachusetts Medical Center Worcester Massachusetts

32. Division of Hematologic Malignancies and Cellular Therapy Duke University Durham North Carolina

33. Division of Hematology/Oncology Department of Medicine Vanderbilt University Medical Center Nashville Tennessee

34. Division of Hematology and Oncology Center for Cell and Gene Therapy Baylor College of Medicine Houston Texas

35. Department of Hematology/Oncology Mayo Clinic Phoenix Arizona

36. Division of Hematology/Oncology Department of Medicine University of North Carolina Chapel Hill North Carolina

37. Department of Internal Medicine Mayo Clinic Rochester Minnesota

38. Department of Medicine Roswell Park Comprehensive Cancer Center Buffalo New York

Funder

Office of Naval Research

Health Resources and Services Administration

National Heart, Lung, and Blood Institute

National Cancer Institute

Medical College of Wisconsin

AbbVie

Actinium Pharmaceuticals

Amgen

Astellas Pharma US

AstraZeneca

Bristol-Myers Squibb

Celgene

CSL Behring

Daiichi-Sankyo

Genzyme

GlaxoSmithKline

HistoGenetics

Janssen Biotech

Janssen Pharmaceuticals

Jazz Pharmaceuticals

Kiadis Pharma

Kyowa Hakko Kirin

Merck

Merck Sharp and Dohme

Miltenyi Biotec

Novartis Pharmaceuticals Corporation

Pfizer

Regeneron Pharmaceuticals

Seattle Genetics

Takeda Oncology

Takeda Pharmaceuticals U.S.A.

Terumo BCT

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33232

Reference33 articles.

1. Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation

2. Racial disparities in hematopoietic cell transplantation in the United States

3. Access to Hematopoietic Cell Transplantation in the United States

4. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes

5. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis;Transplantation and Cellular Therapy;2023-11

2. Initial steps towards improving quality of care for allogeneic hematopoietic cell transplantation recipients at individual centers;Transplantation and Cellular Therapy;2023-08

3. Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program;Best Practice & Research Clinical Haematology;2023-06

4. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem;Transplantation and Cellular Therapy;2022-12

5. Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia;eJHaem;2022-10-18